Objective: High fatigability, a dysfunctional adaption to fatigue, may lead to difficulties performing otherwise regularly encountered cognitive activities and may be related to pro-inflammatory reactivity. The purpose of the study was to investigate the effect of fatigability on cognitive processes and inflammatory response after an acute cognitive stress task in older adults. Methods: In an observational stress reactivity study conducted in a light-and temperature-controlled laboratory, we measured IL-6, self-reported acute fatigue, and frontally oriented cognitive processes in 55 community-dwelling individuals aged 75 years or older as part of a demanding set of cognitive tasks intended to induce stress. Results: Subjects were classified into groups of low and high fatigability based on cluster analysis of their self-report acute fatigue before and after the cognitive tasks. The two clusters were comparable on levels of baseline IL-6 and cognitive processes; however, the high fatigability cluster had significantly higher levels of IL-6 response than the low fatigability cluster. After controlling for multiple covariates, fatigability moderated the relationship between speed of processing and IL-6 reactivity. Further exploratory analyses indicated significant adverse associations between speed of processing and attention and IL-6 reactivity in the group with low but not high fatigability. Conclusion: Although observational, these data are consistent with the notion that pro-inflammatory states in older adults might be reduced by improvements in cognitive processes. Because fatigability was associated with increased acute inflammatory response and disrupted the normal stress regulation provided by the cognitive processes, future randomized studies might examine whether fatigability alleviation reduces IL-6. (Am J Geriatr Psychiatry 2013; -:-e-)
INTRODUCTION
Stress reactivity, an individual's immediate emotional and/or physiologic response to a stressor, is a critical component of stress regulation and independently predicts future health events. 1 Immune response to stressors is an important part of stress reactivity. 2 According to a meta-analysis on inflammatory reactivity to stress, the most consistently observed inducible response comes from IL-6, 3 and multiple mechanisms may help explain the peripheral inflammatory reactivity to acute stress (e.g., up-regulated synthesis of peripheral inflammatory markers, changes in plasma volume, and increases in the number of cytokine-synthesizing cells contributing to circulatory levels). 3 However, none of the mechanisms is related to the potential top-down regulatory role of the central nervous system in peripheral inflammatory reactivity. Psychophysiologic models of stress regulation suggest the frontal-limbic network, which includes several cortical regions (i.e., prefrontal cortex, anterior cingulate cortex, and insular cortex) and their communication with subcortical regions (i.e., hypothalamus and thalamus) and the hypothalamic-pituitary-adrenal axis, plays a direct role in regulating physiologic responses to stress. These cortical regions can affect the transmission of signals related to inflammatory response from two parallel pathways: vagal as well as spinal visceral and somatic sensory. 4, 5 The degeneration of these cortical regions occurs early in both normal and abnormal aging processes and shifts regulation of inflammatory processes from a homeostatic balance between anti-and pro-inflammatory statuses in early life to a pro-inflammatoryedominated status in late life. 6, 7 Such an age-related shift may reduce psychophysiologic adaptation to stressors and render older adults susceptible to exaggerated inflammatory responses to stressors, including peripheral inflammatory responses. 8 Alterations in the function of these cortical regions, especially the prefrontal cortex (e.g., applying mindfulness training), have been shown to decrease the peripheral pro-inflammatory cytokine gene expression in old age. 9, 10 These cortical regions also mediate executive function (EF), speed of processing (SOP), and attention. 11, 12 Williams et al. 13 proposed that these frontally oriented cognitive processes are involved in the top-down regulation of individuals' stress responses, including peripheral inflammatory responses. However, this hypothesis has not been tested empirically. Stress reactivity may not only be affected by cognitive function; conversely, assessments of cognitive function are often themselves perceived as stressors. In fact, in a meta-analysis of acute laboratory mental stress, cognitive assessments for skilled sequences, working memory, and sustained attention fell among the most commonly applied laboratory stressors in acute stress reactivity studies. 14, 15 Older adults' perceptions of this stressor can be captured indirectly through assessments of fatigability, a dysfunctional adaption to fatigue. 16 Fatigue is one of the most common somatic symptoms reported by older adults, 17 resulting from a mismatch between task-related energy requirements and available energy resources. 18 Emerging behavioral studies found that fatigability, especially in the format of self-report, is not necessarily related to the scores on cognitive tests themselves 19 but that higher levels of fatigability elicit greater IL-6 reactivity. 20 From a pathophysiologic perspective, disturbed glucocorticoid receptor function and endocrine response and/or unbalanced homeostasis due to bioenergic changes from the acute stress task 21, 22 may link fatigability with pro-inflammatory reactivity peripherally. From a neuroanatomic perspective, perceived fatigability is reflected as a dysfunctional cerebral activity in the basal ganglia, involving contributions from the frontal cortex (including prefrontal cortex and anterior cingulate cortex), thalamus, and the amygdale. 23 Given the overlap of fatigability-related cortical regions with frontal-limbic networks that attend to stress regulation, fatigability possibly affects peripheral inflammatory reactivity by disrupting the central regulation on peripheral inflammatory responses to acute stress. 16 In the present study, we tested the hypothesis that fatigability would disrupt the effect of frontally oriented cognitive processes on IL-6 response to acute stress. There were three specific aims in the present study: (1) to characterize IL-6 reactivity and fatigability to the cognitive stress task, (2) to examine the association between frontally oriented cognitive processes (i.e., EF, SOP, and attention) and IL-6 reactivity, and (3) to test fatigability as a moderator of the relationship between frontally oriented cognitive processes and IL-6 reactivity.
METHODS

Design and Participants
We conducted an observational laboratory stress reactivity study on 55 participants recruited from local community senior centers in a medium-sized northeastern U.S. city. Inclusion criteria were as follows: (1) English speaking, (2) aged 75 years or older, (3) self-reported adequate auditory and visual acuity for testing, and (4) community dwelling. Exclusion criteria were (1) self-or clinician-reported clinically diagnosed dementia or mild cognitive impairment, (2) treatment with any cholinesterase inhibitors (e.g., donepezil, galatamine, rivastigmine) or memantine within 3 years, and (3) self-reported history of stroke, clinical sleep disorders, or major depression. The study was approved by the University-affiliated Institutional Review Board.
Procedure
All testing took place by trained master-prepared research assistants in the CogT Study Laboratory (principle investigator: FL) at the University of Rochester. During the visit to the light-and temperature-controlled laboratory, the participant was first asked to sit quietly and relax for 5 to 10 minutes to adapt to the environment. The participant then completed a trait fatigue questionnaire and cognitive tests. Self-report acute fatigue was assessed before and immediately after cognitive tests. The blood sample (for IL-6) was collected immediately before cognitive tests (baseline) and 20 minutes after cognitive tests (approximately 50 minutes after the baseline sample was collected). To control for the diurnal fluctuation of IL-6 level, we attempted to arrange interviews within a 2-hour window (8e10 A.M.). Eleven participants (20%) in a random subgroup completed interviews at 1 P.M. A comparison between the IL-6 data collected in the morning and the IL-6 data collected in the afternoon was conducted (see Results). All other demographic and health data were obtained after cognitive tests.
Measurements
Frontally oriented cognitive processes. A series of cognitive tests designed to measure specific aspects of frontally oriented cognition known to be affected by aging 7 Fatigability was operationalized as the change between self-reported acute fatigue before and after the series of cognitive tests. Both before and after the cognitive tests, participants were presented with an acute fatigue rating scale visual analogue scale to evaluate fatigue severity consisting of 18 items measuring varying aspects of fatigue (e.g., "concentrating is a tremendous chore," "energetic," etc.). They indicated their response by placing a mark on a 10-cm analogue rating line ranging from 0 cm (not at all) to 10 cm (extremely). 33 The length of line between 0 and the participant's mark indicated the level of acute fatigue and was recorded for each item. A mean score was developed for the 18 items with higher scores indicating higher levels of acute fatigue.
In the present study, Cronbach's a for the acute fatigue measure before and after the cognitive tasks were 0.88 and 0.94, respectively. This scale has been
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IL-6 assay. A capillary blood sample was collected in the form of a dried blood spot (DBS). The DBS technique of sample collection has been described as suitable for assaying a wide range of chemokines and cytokines, including IL-6. 35, 36 Blood was obtained from a finger prick made with a lancet (2.8-mm depth, 21 gauge). At each time point (baseline and 50 minutes follow-up), five blood drops were absorbed, one drop at a time, onto filter paper (903 Protein Saver; Watman) and then dried at room temperature for a minimum of 4 hours. The paper was the stored at À80 C in an air-tight plastic bag with a desiccant packet until analysis. The analysis was performed with a Quantikine HS ELISA Human IL-6 kit (R&D Systems) using a previously published method with modification.
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A calibration curve specific for a DBS sample was prepared using erythrocytes mixed with calibrator diluent containing serial dilutions of human recombinant IL-6 to create concentrations from 0 to 25 pg/mL. For elution, 6-mm disks were punched from DBS standards, samples, and controls and placed into 96-well plate. Two hundred microliters of elution buffer (Tris-buffered saline, 0.1% Tween-20) were added to each well, and the plate was sealed with adhesive tape and incubated overnight at 4 C and then at room temperature on a rotary shaker (100 rounds per minute) for 30 minutes. The eluate was then transferred onto an ELISA plate provided with the kit, and the ELISA was performed according to the manufacturer's instructions. The IL-6 concentration in patient samples was calculated from a fivepoint fit standard curve. The detection limit of the assay as performed in our laboratory was 0.37 pg/ mL (concentration corresponding to the optical density, which was two standard deviations [SDs] greater than the mean of 10 replicates of calibrator containing 0 pg/mL IL-6). For the samples assayed in duplicates, the correlation between duplicates was high (Pearson's correlation r ¼ 0.95).
A total of 46 participants had measurable IL-6 at both baseline and the 50-minute follow-up. One participant's IL-6 level at baseline was more than 10 pg/mL. We considered this value an outlier indicating potential acute inflammation or infection, and this participant's IL-6 data were excluded from the analysis. We compared participants with (N ¼ 45) and without (N ¼ 10) IL-6 data, and they did not differ in any demographic and health characteristics.
Other demographic characteristics and health variables. Age, gender, years of education, and race/ ethnicity were collected via self-report. Trait fatigue was measured by a mean score of the 20-item Multidimensional Fatigue Inventory, 37 which captures five domains of trait of fatigue in individuals' daily lives: mental fatigue, physical fatigue, general fatigue, reduced motivation, and reduced activities. Participants responded using a scale from 1 ¼ "yes, that is true" to 7 ¼ "no, that is not true." Higher scores indicated high level of trait fatigue. Internal consistency for this measure was 0.89 in this study. Depressive symptoms were measured by the 15-item Geriatric Depression Scale. 38 Participants responded to questions related to their depressive symptoms during the past week using "yes" or "no." A total depressive symptom score was calculated as the total number of answers indicating potentially depressive symptoms. Sleepiness was measured by the eight-item Epworth scale. 39 Participants responded to questions related to their sleepiness (in contrast to feeling just tired) under different situations (e.g., sitting and reading) using a scale ranging from 0 ¼ "would never doze" to 3 ¼ "high chance of dozing." A mean score was computed with higher scores indicating more sleepiness. Internal consistency of the scale was 0.68 in this study. Participants' health conditions (hypertension, high cholesterol, diabetes, obesity) were obtained by self-report. Their medications, specifically antiinflammatory drugs (e.g., aspirin, ibuprofen, and naproxen) and beta-blockers (e.g., atenolol, propranolol, and metoprolol), were extracted from the medication list participants brought to the study.
Data Analysis
Analyses were conducted using IBM SPSS 19.0 (Chicago, IL). Descriptive statistics were first computed. Change of IL-6 from baseline to the 50-minute follow-up was analyzed using a paired t test. To classify the level of fatigability in response to the cognitive tests, a cluster analysis using both selfreport acute fatigue rating before and after the cognitive tests was performed in two steps as suggested by Clatworthy and colleagues, 40 who showed the method was viable in small samples (i.e., as low as the low 40s). First, a hierarchical cluster analysis using Ward's Method identified the number of homogenous clusters. The dendrogram plot was examined to determine the number of clusters (two clusters in this study). Second, using the number of clusters identified in step 1, a K-means cluster analysis of the two fatigue variables was performed. These variables had relatively normal distributions (kurtosis: 1.44 and À0.06, respectively; skewness: 0.80 and 0.63, respectively). After the two steps, the 55 participants were classified into one of the two fatigability clusters.
To compare the main variables and covariates by fatigability cluster, independent t tests and c 2 tests
were used for continuous and categorical variables, respectively. Analysis of covariance was used if any confounding factors needed to be controlled. To examine the association of IL-6 response with demographic and health variables, Pearson's r was used for continuous variables and Spearman's r for categorical variables.
To examine the association of frontally oriented cognitive processes and fatigability and their relationships with IL-6 response, Generalized Linear Models were applied, setting low fatigability cluster as a reference group. The equation was as follows: Y IL-6 response ¼ b0 þ b1 confoudning factor 1. þ bn confounding factor n þ b(nþ1) domain of cognitive processes þ b(nþ2) fatigability þ b(nþ3) domain of cognitive processesÂ fatigability þ ε domain of cognitive processes . The interaction term in this model provided the statistical test of whether the two fatigability groups differed in IL-6 response. After performing the formal test of interaction, we then examined the association between cognitive processes and IL-6 response within the two fatigability clusters separately to estimate the associations in each cluster. Equations were similar to the ones described above without the term of fatigability or fatigability Â cognitive processes. In Generalized Linear Model analyses, age, gender, antiinflammation medication, beta-blocker, depression, sleepiness, trait fatigue, and baseline IL-6 were confounding factors.
Unless specifically defined as raw data, IL-6 data at baseline and at the 50-minute follow-up were logtransformed. IL-6 response was computed as a discrepancy score of IL-6 raw data at the 50-minute follow-up and at baseline. Statistical significance for all analyses was set at p <0.05.
RESULTS
Sample Characteristics
The average age of participants was 82.95 years, and 43.6% were men. The level of education for the sample was equivalent to a college degree. All participants were white. With respect to health characteristics, hypertension was the most prevalent vascular risk factor, and participants reported low levels of sleepiness, trait fatigue, and few depressive symptoms.
IL-6 Reactivity
For the entire sample, there was a small change between baseline IL-6 (raw data: mean ¼ 1.75 pg/ mL, SD ¼ 1.34) and IL-6 at the 50-minute follow-up (raw data: mean ¼ 2.08 pg/mL, SD ¼ 1.86) (paired 
Fatigability Clusters
Two clusters were identified (Fig. 1 ). One group (N ¼ 33) had low levels of fatigue before the cognitive tests (mean ¼ 1.49, SD ¼ 0.62), which remained low after the cognitive tests (mean ¼ 1.65, SD ¼ 0.62). The change in acute fatigue level before and after the cognitive tests was nonsignificant for this group (paired t test ¼ À1.79, df ¼ 32, p ¼ 0.08). This cluster was labeled "low fatigability." The other group (N ¼ 22) had moderate levels of acute fatigue before the cognitive tests (mean ¼ 2.75, SD ¼ 0.91), which increased after cognitive tests (mean ¼ 3.71, SD ¼ 0.92). The change in acute fatigue level before and after the cognitive tests was significant for this group (paired t test ¼ À3.94, df ¼ 21, p ¼ 0.001). This cluster was labeled as "high fatigability."
There were significantly more male participants in the low fatigability cluster than in the high fatigability cluster (c 2 ¼ 6.52, p ¼ 0.014). Participants in the low fatigability cluster had significantly lower levels of trait fatigue (t ¼ À2.52, p ¼ 0.015) and depressive symptoms (t ¼ À3.22, p ¼ 0.002) compared with those in the high fatigability cluster. The two clusters did not differ in other demographic parameters, health characteristics, or any domains of cognitive processes ( Table 1) .
Difference of IL-6 at Baseline and IL-6 Response by Fatigability Cluster
Twenty-three participants (60%) showed increased IL-6 in response to cognitive tests. We examined the correlations between IL-6 response and demographic and health variables, and the only Table 1 displays the IL-6 plasma concentrations in the two fatigability clusters, which did not differ in baseline IL-6. We examined the cognitive teste related change of IL-6 response by fatigability cluster. Controlling for age, gender, anti-inflammatory medication, depression, and baseline IL-6, the high fatigability cluster had a significantly greater change in IL-6 response (mean ¼ 0.64, SD ¼ 1.63) than the low fatigability cluster (mean ¼ 0.13, SD ¼ 0.72) (F (1,42) ¼ 5.32, p ¼ 0.027). Figure 2 displays the change of IL-6 at baseline and at the 50-minute follow-up by fatigability cluster.
Frontally Oriented Cognitive Processes and IL-6 Response
After controlling for age, gender, antiinflammation medication, beta-blocker, depression, sleepiness, trait fatigue, and baseline IL-6, the main effects of the cognitive processes (i.e., EF, SOP, and attention) on IL-6 response were nonsignificant (Model a, Table 2 ).
Interaction of Cognitive Processes and Fatigability on IL-6 Response
There was a significant interaction effect of SOP (not EF or attention) and fatigability on IL-6 response (Model b, Table 2 ). To clarify the interaction effect, we examined the association between SOP and IL-6 response within the two fatigability clusters, controlling for age, gender, anti-inflammation medication, beta-blocker, depression, sleepiness, chronic fatigue, and baseline IL-6 (Model b, Table 3 ). As seen in Figure 3b , there was a significant association between lower SOP and higher IL-6 response in the low fatigability cluster; there was no association between SOP and IL-6 response in the high fatigability cluster.
We also further examined the association between attention and EF and IL-6 response by fatigability cluster (Models a and c, Table 3 ). As seen in Figure 3a , there was no association between EF and IL-6 response in low or high fatigability cluster. As seen in Figure 3c , there was a significant association between lower attention and higher IL-6 reactivity in the low, but not high, fatigability cluster.
DISCUSSION
In the present study, we found a small but not statistically significant (p ¼ 0.066) change in IL-6 from baseline to 20 minutes after a set of acute cognitively stressful tasks (i.e., 30 minutes of cognitive testing). We were able to identify two clusters of fatigability based on individuals' self-reported fatigue at baseline and after the series of cognitive tests. One group had low levels of fatigue at baseline that did not increase significantly over time, and the other had relatively high levels of fatigue at baseline that increased significantly over time. The two fatigability clusters had comparable frontally oriented cognitive performance (i.e., EF, SOP, attention) and IL-6 levels at baseline; however, they significantly differed in their IL-6 reactivity, with the high fatigability group showing greater IL-6 reactivity. There was no association between frontally oriented cognitive processes and IL-6 reactivity as a total sample. However, we found that fatigability moderated the relationship between cognitive processes, especially SOP, and IL-6 reactivity. When further analyzing the associations between cognitive processes and IL-6 reactivity by FIGURE 2. Relationship between fatigue and IL-6 before and after cognitive tests. Note: IL-6 data were log transformed. Adjusted mean indicates IL-6 data presented were controlled for age, gender, antiinflammatory medication, and depressive symptoms.
fatigability cluster, in addition to SOP, attention was also significantly negatively associated with IL-6 reactivity in lower, but not higher, fatigability cluster. All these effects were independent from the influence of age, gender, sleepiness, depressive symptoms, vascular risk factors, trait fatigue, and baseline IL-6. Most of the literature on IL-6 response to acute stress suggests that the increase of IL-6 is delayed and may be most apparent 2 hours after exposure to an acute stressor. 41 In this study, the average increase of IL-6 from baseline to the 50-minute follow-up was approximately 0.33 pg/mL for the total sample, and although not statistically significant at our small sample size, the change was comparable with that of previous studies with a similar interval between stressor and IL-6 measurement. 41 We then identified two fatigability clusters that distinguish the IL-6 response at the 50-minute follow-up (or 20 minutes after the acute stress). These findings suggest that perceived fatigability may predict inflammatory reactivity to stress, adding new information to support the notion that fatigue may signal proinflammatory processes. 42 Importantly, although vascular risks were prevalent in this sample, they did not significantly differ between the two fatigability clusters and were even controlled in analyses, indicating that vascular risk factors are probably not the cause of the difference in IL-6 reactivity. However, such assumption may need further testing, given the lack of objective measures of these vascular risks (e.g., body mass index, glucose, blood pressure). Because fatigability is a dynamic adaptation to an acute stressor, it is not surprising that IL-6 at baseline, which reflects more chronic states of stress, did not differ between the two fatigability clusters. An important finding of the present study is that fatigability was in particular found to be a significant moderator of SOP's effect on IL-6 response. Of note, SOP is not a simple psychomotor ability but a fundamental brain process related to temporary information manipulation. 43, 44 According to a review, SOP reflects the integrity of multiple neural networks involved in other levels or domains of cognitive processes (e.g., attention, EF) and most higher-order cognitive functions (e.g., memory, reasoning, and language). 11 Previous studies found that increased fatigability can specifically affect medial and lateral frontal cortex independent of basal ganglia inputs, 23 whereas atrophy of these frontal regions often occurs early in individuals with decreased SOP, making these regions particularly vulnerable to adverse impact of fatigability. 11 It is possible that fatigability will first and primarily influence this most fundamental and vulnerable cognitive process by disrupting the control of SOP on different formats of stress responses. The other interesting exploratory finding here is the dissociable patterns of association between frontally oriented cognitive processes and inflammatory reactivity by fatigability cluster. That is, the link between cognitive processes and IL-6 response exists only in individuals who perceive little conflict between intrinsic energy resources and the apparent demands of the stressor. Specifically, among persons who do not easily fatigue, greater SOP and attention were associated with lower IL-6 reactivity. In this group, persons who scored higher on these cognitive tests may have better relevant brain functions on stress regulation. In contrast, no association between cognitive scores and IL-6 reactivity was observed among easily fatigable individuals. Among these already fatigued persons, other processes may "overpower" the role cognitive performance plays in predicting IL-6 reactivity. For instance, other factors implicated in elevating IL-6 include poor physical (i.e., number of chronic conditions, physical frailty) and psychological health (i.e., low levels of wellbeing, negative affect). 45e47 Although our study had strict selection criteria to exclude individuals with poor health on some indices, this explanation cannot be ruled out. Variation among nonexclusionary criteria might trump the impact of cognitive processes on IL-6 response among fatigued persons. A second possibility is there may be a high rate of neuropathologic deficits in how basal ganglia work with the limbic system in the easily fatigable group. When self-appraised fatigability is high, the functional connectivity of the brain regions that adapt to acute stress and diminish acute inflammatory response may be disrupted. The potential regulatory effect of cognitive processes on acute inflammatory processes can thus be affected. 23 In contrast, the lack of significant finding in the domain of EF may be related to the tests we used. In addition to the limitations discussed above, other limitations of the study design may also affect our interpretations. First, a small proportion of participants were interviewed beyond the 2-hour window (8e10 A.M.). We did not find a statistically significant difference in IL-6 levels between different data collection points (morning versus afternoon) among participants, and time of day was random with respect to cognitive function and fatigability. Previous literature suggests the IL-6 may exhibit a diurnal rhythm that follows the sleepewake cycle, which is not necessarily related or reflected in a morningeearly afternoon difference. 48 Regardless, future studies may still consider holding to a strict 2-hour window for consistency. Second, as a study using cognitive testing as an acute stressor, we were not able to completely disentangle fatigability from IL-6 response because they were measured contemporaneously rather than serially. That is, the relations between IL-6 reactivity and fatigability as well as IL-6 reactivity and cognitive capacity may be bidirectional. 49 Future studies may temporally separate the stressor induce fatigability and IL-6 response from the cognitive tests. Third, we found gender differences in fatigability. However, the existing studies report inconsistent findings regarding the relationships.
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Future studies with larger sample sizes might separate the examination of fatigability or the effect of fatigability by sex instead of simply using it as a covariate. Finally, we excluded individuals with major depression or clinical sleep disorders from the study to isolate fatigability by design. However, given the theoretically high correlations between fatigue, sleepiness, and depression, 16 it will be worthwhile to explore whether these three phenomenon are jointly associated with the cognitioneinflammatory response link.
Inflammation is recognized as a potent risk factor for psychiatric and physical morbidity and mortality in older adults. It is therefore important to understand the potentially modifiable contributors to not only chronic but also stress-induced levels of pro-inflammatory cytokines. Poor performance on cognitive tasks supported by the frontal lobe may be one potential contributor, or at least predictive sign, in some individuals. If future work establishes a causal connection, attention and SOP may be plausible targets for interventions designed to ameliorate inflammation among individuals with low fatigue. For older adults who easily feel fatigable, scrutinizing potential neuropathologic changes in relevant brain networks may be valuable. Finally, because fatigability was associated with increased acute inflammatory response and disrupted stress regulation provided by cognitive processes, future studies should also clarify the causal role of fatigability, if any, and consider fatigue interventions as appropriate.
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